These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 1561795)
81. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features. Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759 [TBL] [Abstract][Full Text] [Related]
82. The dysplastic nevus. Separate entity, melanoma precursor or diagnostic dilemma? Roesch A; Landthaler M; Vogt T Hautarzt; 2003 Sep; 54(9):871-83; quiz 884-5. PubMed ID: 14575036 [TBL] [Abstract][Full Text] [Related]
83. Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. Slade J; Marghoob AA; Salopek TG; Rigel DS; Kopf AW; Bart RS J Am Acad Dermatol; 1995 Mar; 32(3):479-94. PubMed ID: 7868720 [TBL] [Abstract][Full Text] [Related]
85. Consensus on the management of melanoma of the skin in The Netherlands. Dutch Melanoma Working Party. Rümke P; van Everdingen JE Eur J Cancer; 1992; 28(2-3):600-4. PubMed ID: 1591078 [TBL] [Abstract][Full Text] [Related]
86. Accuracy in the clinical diagnosis and pattern of malignant melanoma at a dermatological clinic. Lindelöf B; Hedblad MA J Dermatol; 1994 Jul; 21(7):461-4. PubMed ID: 8089364 [TBL] [Abstract][Full Text] [Related]
87. Novel multiple markers to distinguish melanoma from dysplastic nevi. Zhang G; Li G PLoS One; 2012; 7(9):e45037. PubMed ID: 23028750 [TBL] [Abstract][Full Text] [Related]
88. Dermatological perspectives of malignant melanoma. Swetter SM Surg Clin North Am; 2003 Feb; 83(1):77-95, vi. PubMed ID: 12691451 [TBL] [Abstract][Full Text] [Related]
89. The dangers of atypical mole (dysplastic nevus) syndrome. Teaching at-risk patients to protect themselves from melanoma. Marghoob AA Postgrad Med; 1999 Jun; 105(7):147-8, 151-2, 154 passim. PubMed ID: 10376056 [TBL] [Abstract][Full Text] [Related]
90. Routine total skin examination to detect malignant melanoma. Boyce JA; Bernhard JD J Gen Intern Med; 1987; 2(1):59-61. PubMed ID: 3543269 [No Abstract] [Full Text] [Related]
96. A novel surgical margin (1 cm) might be from benefit for patients with dysplastic nevi, thin melanomas, and melanoma in situ: Analysis based on clinical cases. Tchernev G; Malev V; Patterson JW; Lotti T Dermatol Ther; 2020 Mar; 33(2):e13261. PubMed ID: 32043684 [TBL] [Abstract][Full Text] [Related]
97. [Screening and prevention of malignant melanoma]. Delaunay MM Presse Med; 1990 Jan; 19(3):108-10. PubMed ID: 2137585 [No Abstract] [Full Text] [Related]
98. Impact of dermoscopy on the management of high-risk patients from melanoma families: a prospective study. van der Rhee JI; Bergman W; Kukutsch NA Acta Derm Venereol; 2011 Jun; 91(4):428-31. PubMed ID: 21625824 [TBL] [Abstract][Full Text] [Related]
99. The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management. Duffy K; Grossman D J Am Acad Dermatol; 2012 Jul; 67(1):19.e1-12; quiz 31-2. PubMed ID: 22703916 [TBL] [Abstract][Full Text] [Related]
100. Do we need to rethink the diagnoses melanoma in situ and severely dysplastic naevus? Semsarian CR; Ma T; Nickel B; Scolyer RA; Ferguson PM; Soyer HP; Parker L; Barratt A; Thompson JF; Bell KJL Br J Dermatol; 2022 Jun; 186(6):1030-1032. PubMed ID: 35007335 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]